{"name": "Senesco Technologies",
 "permalink": "senesco-technologies",
 "crunchbase_url": "http://www.crunchbase.com/company/senesco-technologies",
 "homepage_url": "http://www.senesco.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@senesco.com",
 "phone_number": "908-864-4444",
 "description": "",
 "created_at": "Wed Jul 21 03:30:58 UTC 2010",
 "updated_at": "Fri Apr 13 22:52:13 UTC 2012",
 "overview": "\u003Cp\u003ESenesco Technologies, Inc., a development stage biotechnology company, focuses on the development of technologies to treat programmed cell death diseases in humans. Its technologies are also used to enhance the productivity of fruits, flowers, vegetables, forestry species, and agronomic crops through the control of cell death in plants. The company was founded in 1964 and is headquartered in Bridgewater, New Jersey.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       79],
      "assets/images/resized/0009/4397/94397v1-max-150x150.png"],
     [[174,
       92],
      "assets/images/resized/0009/4397/94397v1-max-250x250.png"],
     [[174,
       92],
      "assets/images/resized/0009/4397/94397v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President \u0026 CEO \u0026 Director",
    "person":
     {"first_name": "Leslie",
      "last_name": "J. Browne",
      "permalink": "leslie-j-browne",
      "image":
       {"available_sizes":
         [[[104,
            140],
           "assets/images/resized/0025/5952/255952v1-max-150x150.jpg"],
          [[104,
            140],
           "assets/images/resized/0025/5952/255952v1-max-250x250.jpg"],
          [[104,
            140],
           "assets/images/resized/0025/5952/255952v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$11.5M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.senesco.com/newsitem.php?id=197",
    "source_description": "Senesco Technologies, Inc. Announces Private Placement Financing for Gross Proceeds of $11.5 Million. Funds to be Utilized to Advance Lead Multiple Myeloma Drug Candidate into Phase 1b/2a Clinical Trial ",
    "raised_amount": 11500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 3,
    "funded_day": 29,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Defiance Capital",
         "permalink": "defiance-capital",
         "image":
          {"available_sizes":
            [[[150,
               15],
              "assets/images/resized/0010/1389/101389v1-max-150x150.jpg"],
             [[250,
               25],
              "assets/images/resized/0010/1389/101389v1-max-250x250.jpg"],
             [[345,
               35],
              "assets/images/resized/0010/1389/101389v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Hudson Bay Capital Management",
         "permalink": "hudson-bay-capital-management",
         "image":
          {"available_sizes":
            [[[150,
               64],
              "assets/images/resized/0008/0380/80380v1-max-150x150.jpg"],
             [[250,
               107],
              "assets/images/resized/0008/0380/80380v1-max-250x250.jpg"],
             [[450,
               192],
              "assets/images/resized/0008/0380/80380v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Linden Asset Management",
         "permalink": "linden-asset-management",
         "image":
          {"available_sizes":
            [[[150,
               24],
              "assets/images/resized/0010/2624/102624v1-max-150x150.png"],
             [[250,
               40],
              "assets/images/resized/0010/2624/102624v1-max-250x250.png"],
             [[290,
               47],
              "assets/images/resized/0010/2624/102624v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Next View Partners",
         "permalink": "next-view-partners",
         "image": null},
       "person": null},
      {"company":
        {"name": "InterGroup",
         "permalink": "intergroup",
         "image": null},
       "financial_org": null,
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Alpha Capital",
         "permalink": "alpha-capital",
         "image":
          {"available_sizes":
            [[[150,
               27],
              "assets/images/resized/0006/1137/61137v2-max-150x150.jpg"],
             [[250,
               46],
              "assets/images/resized/0006/1137/61137v2-max-250x250.jpg"],
             [[448,
               83],
              "assets/images/resized/0006/1137/61137v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Chestnut Ridge Capital",
         "permalink": "chestnut-ridge-capital",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Midsummer Capital",
         "permalink": "midsummer-capital",
         "image":
          {"available_sizes":
            [[[150,
               91],
              "assets/images/resized/0006/1136/61136v1-max-150x150.jpg"],
             [[198,
               121],
              "assets/images/resized/0006/1136/61136v1-max-250x250.jpg"],
             [[198,
               121],
              "assets/images/resized/0006/1136/61136v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Iroquois Capital",
         "permalink": "iroquois-capital",
         "image":
          {"available_sizes":
            [[[150,
               45],
              "assets/images/resized/0025/2096/252096v1-max-150x150.png"],
             [[250,
               75],
              "assets/images/resized/0025/2096/252096v1-max-250x250.png"],
             [[267,
               81],
              "assets/images/resized/0025/2096/252096v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Perceptive Advisors",
         "permalink": "perceptive-advisors",
         "image":
          {"available_sizes":
            [[[150,
               26],
              "assets/images/resized/0026/0616/260616v1-max-150x150.jpg"],
             [[250,
               43],
              "assets/images/resized/0026/0616/260616v1-max-250x250.jpg"],
             [[432,
               75],
              "assets/images/resized/0026/0616/260616v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "The Hewlett Fund",
         "permalink": "the-hewlett-fund",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Northern Rivers Capital Management",
         "permalink": "northern-rivers-capital-management",
         "image":
          {"available_sizes":
            [[[150,
               82],
              "assets/images/resized/0010/2866/102866v2-max-150x150.jpg"],
             [[170,
               94],
              "assets/images/resized/0010/2866/102866v2-max-250x250.jpg"],
             [[170,
               94],
              "assets/images/resized/0010/2866/102866v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Whalehaven Capital Fund",
         "permalink": "whalehaven-capital-fund",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Heights Capital Management",
         "permalink": "heights-capital-management",
         "image": null},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "721 Route 202/206",
    "address2": "Suite 130",
    "zip_code": "08807",
    "city": "Bridgewater",
    "state_code": "NJ",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo":
  {"valuation_amount": null,
   "valuation_currency_code": "USD",
   "pub_year": null,
   "pub_month": null,
   "pub_day": null,
   "stock_symbol": "AMEX:SNT"},
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}